Does prophylactic thyroxine treatment after operation for non-toxic goitre influence thyroid size?

Area of Science:

• Endocrinology
• Surgical Oncology
• Thyroid Research

Background:

• Thyroidectomy is a common surgical procedure for non-toxic goiter.
• Postoperative management strategies aim to prevent recurrence and manage thyroid function.
• The role of thyroxine supplementation after thyroidectomy for non-toxic goiter remains debated.

Purpose of the Study:

• To evaluate the influence of thyroxine treatment on thyroid volume after thyroidectomy for non-toxic goiter.
• To assess the impact of thyroxine on goiter recurrence rates.
• To determine the necessity of routine postoperative thyroxine therapy.

Main Methods:

• 110 consecutive patients undergoing thyroidectomy for non-toxic goiter were randomized.
• Patients received either thyroxine (150 micrograms daily) or no treatment, starting three months post-operation.
• Thyroid volume was measured using ultrasonography at baseline and one year post-operation.

Main Results:

• Thyroid volume did not differ significantly between the thyroxine and no-treatment groups one year after surgery.
• A similar decrease in thyroid volume was observed in both groups between three and 12 months postoperatively.
• Goiter recurrence was observed in three patients within the one-year follow-up period, with two in the thyroxine group.

Conclusions:

• Postoperative thyroid volume reduction occurs independently of thyroxine treatment in the first year.
• Routine postoperative thyroxine treatment after thyroidectomy for non-toxic goiter may not be justifiable.
• Further studies are needed to identify patients at risk for goiter recurrence.